Automated insulin delivery after beta-cell replacement failure in people living with type 1 diabetes
This study highlights the effectiveness of AID in achieving glucose control targets and preventing severe hypoglycemia in patients with T1D following βCR failure. AID may serve as a valuable therapeutic option to improve glucose control when graft function declines.
Authors
- Sandrine Lablanche (ORCID: https://orcid.org/0000-0001-7044-8474)
- Orianne Villard (ORCID: https://orcid.org/0000-0002-7420-1425)
- Fanny Buron (ORCID: https://orcid.org/0000-0003-0404-6746)
- Jean‐Baptiste Julla (ORCID: https://orcid.org/0000-0002-4497-5710)
- Luc Rakotoarisoa (ORCID: https://orcid.org/0000-0001-9583-2130)
- Quentin Perrier (ORCID: https://orcid.org/0000-0002-7445-7922)
- S. Reffet
- P.Y. Benhamou
- Laurence Kessler (ORCID: https://orcid.org/0000-0002-1769-5625)
- E. Renard
- Jean‐Pierre Riveline
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Université Paris Cité (FR)
- Regenerative NanoMedicine (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hospices Civils de Lyon (FR)
- Hôpital Lariboisière (FR)
- Grenoble Institute of Neurosciences (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Diabetes & Metabolism
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1016/j.diabet.2025.101654
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.59